Biotage AB (publ) (BITGF) Research

Biotage AB (publ) specializes in advanced separation science solutions for organic and analytical chemistry, biomolecular research, and industrial-scale applications. The company's comprehensive offerings include products for organic and peptide synthesis, flash chromatography, evaporation, and sample work-up, alongside a variety of flash systems, accessories, and chromatographic cartridges (normal, reversed, and specialized phases). Additional solutions encompass plasmid purification, metal scavengers, chemical reagents, and essential spare parts. Biotage also provides extensive sample preparation systems and consumables, catering to diverse fields such as clinical, bioanalytical, forensic, toxicology, human and animal doping control, environmental analysis, and food and agriculture. Furthermore, it delivers specialized protein purification solutions, including systems for antibody and tagged protein purification, automation, custom packing services, and a range of PhyTip columns utilizing ion exchange, reversed phase, normal phase, and gel filtration technologies. Its clientele spans pharmaceutical and biotechnology companies, contract research and manufacturing organizations, government bodies, academic institutions, and various clinical and forensic laboratories. Established in 1969 and headquartered in Uppsala, Sweden, Biotage maintains a global presence, operating in 70 countries across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region.

Open Biotage AB (publ) (BITGF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.